Pharmaceutical company settles civil allegations for $2.8M
by Associated Press
Published: March 29,2012
MADISON — A Mississippi-based pharmaceutical company has agreed to pay $2.8 million to resolve civil allegations that the manufacturer falsely marketed skin products to receive government funding.
U.S. Attorney John M. Bales said yesterday Cypress Pharmaceutical Inc., a subsidiary and CEO Max Draughn will pay $1.6 million to the military’s TRICARE program and $1.2 million to state Medicaid programs.
The government alleges that Cypress subsidiary Hawthorne Pharmaceuticals Inc. claimed that three skin products carried the Food and Drug Administration’s “safe and effective” designation when the treatments didn’t. The government also claims the regulatory status of the products was misrepresented.
Bales says a whistleblower who sued under the False Claims Act received $300,000 as part of the settlement.
An official for Madison-based Cypress didn’t immediately return a phone call seeking comment.
To sign up for Mississippi Business Daily Updates, click here.
Top Posts & Pages
- Omega Protein shifting vessels to Mississippi
- PSC unanimously rejects Entergy-ITC proposed merger
- IKE TROTTER: There are primary changes in Social Security for 2014
- Bankrupt Simply Wheelz chooses prevailing bidder for assets
- CARTOON — Nobile illustrates Thad Cochran's most significant advantage over the competition
- Company mulling plan to build new pipeline
- Judge denies ex-mayor's motion to vacate Katrina-related conviction
- Wiseman retiring after nearly 30 years with Stennis Institute
- Conservator: Schools had too many employees
- Real estate developer to plead guilty to wetlands violation